Idiopathic aplastic anemia is failure of the bone marrow to properly make blood cells.
Anemia - idiopathic aplastic
Causes, incidence, and risk factors:
Bone marrow is the soft tissue in the center of bones. It helps form blood cells.
Aplastic anemia results from injury to the blood stem cell, a cell that develops into other blood cell types. The injury causes a reduction in the number of every type of blood cell in the body -- red cells, white cells, and platelets. Low numbers of red cells, white cells, and platelets is a condition called pancytopenia.
Idiopathic means the cause is unknown. However, idiopathic aplastic anemia is thought to occur when the body reacts against its own cells. This is called an autoimmune disorder.
The disease may be acute or chronic , and may get worse over time. There are no known risk factors.
Aplastic anemia may also be caused by certain medical conditions (such as pregnancy or lupus) or exposure to some toxins or drugs (including chemotherapy). See: Secondary (acquired) aplastic anemia
In some cases, aplastic anemia is associated with another blood disorder called paroxysmal nocturnal hemoglobinuria (PNH).
Symptoms are the result of bone marrow failure and the loss of blood cell production.
Low red cell count (anemia) leads to fatigue and weakness.
Low white cell count (leukopenia) causes an increased risk of infection.
Low platelet count (thrombocytopenia) results in bleeding, especially of the mucous membranes and skin.
General symptoms include:
Mild cases of aplastic anemia may be treated with supportive care or may require no treatment.
In moderate cases, blood transfusions and platelet transfusions will help correct the abnormal blood counts and relieve some symptoms.
Severe aplastic anemia, which is defined as a very low blood-cell count, is a life-threatening condition. Bone marrow transplant or stem cell transplant is recommended for severe disease in younger patients.
For older patients, or for those who do not have a matched bone marrow donor, Atgam or thymoglobulin are alternative treatments. These medicines suppress the body's immune system in a way that allows the bone marrow to once again make blood cells. Atgam may be used in combination with other drugs, such as cyclosporine, tacrolimus, and steroids. Cyclophosphamide (Cytoxan) is another drug that may be used in certain circumstances.
Untreated aplastic anemia leads to rapid death. Bone marrow transplant has been successful in young people, with long term survival rates of about 80%. Older people have a survival rate of 40 - 70%.
- Severe infections or bleeding
- Complications of bone marrow transplant (graft failure or graft-versus-host disease )
- Reactions to medications (patients can have reactions to Atgam)
Calling your health care provider:
Call your health care provider or go to the emergency room if bleeding occurs for no reason, or if bleeding is difficult to stop. Call if you notice frequent infections or unusual fatigue.
There is no known prevention for idiopathic aplastic anemia.
Castro-Malaspina H, O'Reilly R. Aplastic anemia and related disorders. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 171.